Skip to content

Perfectha Lidocaine

by Sinclair France SAS France EUDAMED

Ref PDSSLModel Subskin Lidocaine

EMDN X0303

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number50600330418096121409191JX Basic UDI-DIDate23 Apr 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Not covered

European Union — CE/MDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 22 Oct 2026

Device Name
Perfectha Subskin Lidocaine
Model / Reference
Subskin Lidocaine, PDSSL
Primary DI / UDI-DI
05060033044810
Basic UDI-DI
50600330418096121409191JX
EMDN Code
X0303 Substances, combinations of substances, or items without an intended medical purpose intended to be used for facial or other dermal or mucous membrane filling by subcutaneous, submucous or intradermal injection or other introduction, by a prefilled means for introduction, excluding those for tattooing – resorbable
Device Class
Class III
Medical Purpose
Perfectha Lidocaine product range is intended for facial filling by subcutaneous, submucous, intradermal or supraperiosteal injection. Perfectha Lidocaine is implanted in the areas of the face to fill skin depressions, wrinkles, and fine lines, and for the augmentation of tissue volume.

Manufacturer details

EUDAMED SRN
FR-PR-000053000

Properties & raw data

Show properties, registry sources and raw records
  • Sterile

Sources (1)

  • EUDAMED cdb4f896-2832-4bd9-829e-3d3616184858 61 fields · synced 22 Oct 2026